PDLI Financial Facts

Net income per diluted share (in dollars per share): 0.44
Total revenues: 139.66M
See Full Income Statement

Total liabilities: 650.37M
Total liabilities and stockholders' deficit: 852.58M
See Full Balance Sheet

PDL BioPharma, Inc. (PDLI) Earnings

  |   Expand Research on PDLI
Next EPS Date N/A EPS Growth Rate +4.0%
Average EPS % Beat Rate +0.1% Revenue Growth Rate -7.0%
Average % Move 1-Wk after EPS +2.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/12/14 Q114 $0.44$0.45 -$0.01$139.7M$130.93M N/A Details
3/3/14 Q413 $0.39$0.43 -$0.04$110.1M$115.22M N/A Details
11/6/13 Q313 $0.36$0.37 -$0.01$97.3M$97.09M N/A Details
8/8/13 Q213 $0.62$0.54 +$0.08$143.6M$138.2M N/A Details
5/9/13 Q113 $0.36$0.35 +$0.01$91.8M$91.69M N/A Details
3/1/13 Q412 $0.34$0.32 +$0.02$86M$86.08M N/A Details
11/5/12 Q312 $0.32$0.30 +$0.02$85.2M$85.03M N/A Details
8/2/12 Q212 $0.53$0.49 +$0.04$125.9M$125.14M N/A Details